Chiral catalysis technology is a revolutionary advancement in the field of chemistry that has transformed the way we approach asymmetric synthesis. By utilizing chiral catalysts, which are molecules that possess asymmetry and can selectively bind to specific substrates, researchers are able to control the stereochemistry of chemical reactions with unparalleled precision. This technology has opened up new avenues for the synthesis of complex molecules with high enantioselectivity, leading to the development of new pharmaceuticals.
As a leading biopharmaceutical company, our chiral catalysis technology platform is dedicated to accelerating the drug discovery process and driving innovation in the pharmaceutical industry. With our state-of-the-art facilities and team of experienced experts, we offer customized solutions to meet the diverse needs of our clients in the pharmaceutical industry.
Our Chiral Catalysis Technology Platform
Our chiral catalysis platform offers a range of services aimed at providing tailored solutions for the production of enantiomerically pure compounds including ligands, catalysts, pharmaceutical intermediates and more, thus enabling the development of novel drugs with enhanced potency and reduced side effects. Our advantageous services are as follows:
- Development of efficient asymmetric catalytic reactions
- Development of chiral ligands and catalysts
- Development of scale-up synthesis processes for chiral ligands and catalysts
- Development of chiral drugs and intermediates
- Development of new synthesis processes for chiral drugs and intermediates
Platform Equipment
Our chiral catalysis technology platform is equipped with a wide range of advanced instruments and equipment, enabling us to perform a variety of asymmetric transformations with high efficiency and precision. Our instruments include but are not limited to the following:
- Gas Chromatograph
- High performance liquid chromatograph
- Glove box
- High-pressure reactors of various specifications
- Parallel reaction device
- Continuous hydrogenation reaction device
Platform Advantages
Our chiral catalysis technology platform offers several key advantages that set us apart in the biopharmaceutical industry.
- Powerful synthesis capabilities. Our chiral catalysis technology platform has the ability to conduct general asymmetric reaction mechanism research, providing technical guidance for the development of efficient asymmetric catalytic reactions and ligands. In addition, we have the ability to independently design and synthesize chiral phosphine ligands, chiral small molecule catalysts and chiral metal complexes (catalysts). And we are good at asymmetric hydrogenation, asymmetric Suzuki coupling and asymmetric cycloaddition reactions, providing efficient tools for the synthesis and development of chiral drugs and intermediates.
- Enhanced selectivity. Our technology enables the production of pure enantiomers with high selectivity, reducing the need for costly purification processes and improving overall efficiency.
- Cost-effective production. By selectively producing the desired enantiomer, our chiral catalysis technology platform can help reduce production costs and increase yield, ultimately leading to more cost-effective drug development.
- Improved safety profiles. Producing pure enantiomers can help minimize the risk of unexpected side effects or toxicities associated with the use of racemic mixtures, leading to safer and more effective drugs.
- Accelerated drug development. Our chiral catalysis technology platform can streamline the drug development process by providing a more efficient and reliable method for synthesizing chiral molecules, allowing for faster development timelines and quicker entry into the market.
Related Services
It should be noted that our service is only used for research, not for clinical use.
